|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 249.80 GBX | +0.64% |
|
-7.48% | -11.98% |
| 06-03 | WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track | AN |
| 06-01 | Waldencast announces sale of Obagi Medical to Bridgepoint | RE |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Net Income | 57.8M | 121M | 70.7M | 64.8M | 41.5M | |||
Depreciation & Amortization - CF | 11.9M | 15.3M | 13.7M | 15.1M | 19.1M | |||
Amortization of Goodwill and Intangible Assets - (CF) | 3.1M | 3M | 3M | 19.4M | 48.3M | |||
Depreciation & Amortization, Total | 15M | 18.3M | 16.7M | 34.5M | 67.4M | |||
Amortization of Deferred Charges, Total - (CF) | - | - | 800K | 1.7M | 500K | |||
(Gain) Loss From Sale Of Asset | -600K | 400K | 1.2M | - | - | |||
(Gain) Loss on Sale of Investments - (CF) | -56.9M | -40.7M | -25.3M | -38.8M | -147M | |||
Asset Writedown & Restructuring Costs | - | - | - | - | - | |||
Stock-Based Compensation (CF) | 2.9M | 400K | 4.2M | 38.6M | 64.8M | |||
Other Operating Activities, Total | 17.3M | -25.6M | -23.7M | -15.4M | 70.4M | |||
Change In Accounts Receivable | -10.3M | -46.4M | -5.6M | -6.9M | 10.5M | |||
Change In Accounts Payable | -2.1M | 6.9M | 56M | -67.7M | 27.6M | |||
Cash from Operations | 23.1M | 33.9M | 95M | 10.8M | 136M | |||
Capital Expenditure | -6.3M | -22.6M | -4M | -2.9M | -32.3M | |||
Cash Acquisitions | - | 45.6M | - | -163M | -600K | |||
Investment in Marketable and Equity Securities, Total | -186M | -84.8M | -321M | -770M | -589M | |||
Other Investing Activities, Total | 29.1M | 4.5M | 4.7M | 6.9M | 3.4M | |||
Cash from Investing | -163M | -57.3M | -320M | -929M | -618M | |||
Short Term Debt Issued, Total | - | - | - | 190M | - | |||
Long-Term Debt Issued, Total | 118M | - | 149M | 700M | 308M | |||
Total Debt Issued | 118M | - | 149M | 889M | 308M | |||
Short Term Debt Repaid, Total | - | - | - | -190M | - | |||
Long-Term Debt Repaid, Total | -155M | -19.4M | -265M | -573M | -1.37B | |||
Total Debt Repaid | -155M | -19.4M | -265M | -763M | -1.37B | |||
Issuance of Common Stock | 305M | - | - | - | - | |||
Repurchase of Common Stock | - | - | -60.2M | -9.8M | -4.1M | |||
Common Dividends Paid | -30M | -62.8M | -68M | -73.3M | -78.1M | |||
Common & Preferred Stock Dividends Paid | -30M | -62.8M | -68M | -73.3M | -78.1M | |||
Other Financing Activities, Total | 80.7M | -4.4M | 570M | 733M | 1.8B | |||
Cash from Financing | 319M | -86.6M | 326M | 776M | 652M | |||
Foreign Exchange Rate Adjustments | -8.5M | 3.3M | -6.4M | -13M | 6.1M | |||
Net Change in Cash | 170M | -107M | 94.2M | -155M | 175M | |||
Supplemental Items | ||||||||
Cash Interest Paid | 5.9M | 4.7M | 7.2M | 14.2M | 26.2M | |||
Cash Income Tax Paid (Refund) | 1.4M | 1.7M | 4.7M | 1.5M | 3.7M | |||
Levered Free Cash Flow | 171M | -370M | -430M | 211M | -635M | |||
Unlevered Free Cash Flow | 174M | -367M | -427M | 225M | -613M | |||
Change In Net Working Capital | -101M | 438M | 524M | -34.3M | 878M | |||
Net Debt Issued / Repaid | -37.2M | -19.4M | -116M | 126M | -1.06B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















